# Nonmetastatic Castration-Resistant Prostate Cancer: Considerations for Metastasis-Free Survival Endpoint in Clinical Trials - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/nonmetastatic-castration-resistant-prostate-cancer-considerations-for-metastasis-free-survival-endpoint-in-clinical-trials/c32357fc-c9d0-4e62-95cb-8b3f815da638

> FDA guidance document: Nonmetastatic Castration-Resistant Prostate Cancer: Considerations for Metastasis-Free Survival Endpoint in Clinical Trials. Issue date: August 06, 2021. Get complete insights and analysis.

---

## Details

- Title: Nonmetastatic Castration-Resistant Prostate Cancer: Considerations for Metastasis-Free Survival Endpoint in Clinical Trials
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2021-08-06
- Last Changed: 2021-08-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-3931">FDA-2018-D-3931</a>

## Related Documents

- [Placebos and Blinding in Randomized Controlled Cancer Clinical Trials for Drug and Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/placebos-and-blinding-in-randomized-controlled-cancer-clinical-trials-for-drug-and-biological-products-guidance-for-industry/f88966dd-4dae-4b98-ae6e-e21b153bfb43)
- [General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/general-clinical-pharmacology-considerations-for-neonatal-studies-for-drugs-and-biological-products-guidance-for-industry/0c57731e-55bc-4962-a619-54444aa22335)
- [Considerations for the Inclusion of Adolescent Patients in Adult Oncology Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-the-inclusion-of-adolescent-patients-in-adult-oncology-clinical-trials/d9024369-3d11-4161-a606-70ab031e8871)